Effect of a 12-month Pharmaceutical Care Program on Control of Severe Asthma

Federal University of Bahia

Status: Completed

Conditions: Asthma; Quality of Life

Treatments: Other: Pharmaceutical care

Study type: Interventional

Funder types: Other

Identifiers

NCT01644357

ATENFAR-PROAR

Details and patient eligibility

About

Only a few well-designed studies have investigated the effect of pharmaceutical care on asthma patients and to date there are no published studies investigating this effect specifically on severe and refractory asthma.

The objective of this study is evaluate the effect of pharmaceutical care on asthma control and quality of life (QoL) of patients with severe or refractory asthma compared with pharmacist dispensation only.

Enrollment: 40 patients

Sex: All

Ages: 18 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with severe/refractory asthma presenting other respiratory disease,
• ≥ 18 years of age,
• using high dose of inhaled corticosteroids (≥ 800mcg of budesonide or equivalent)
• FEV1<60%,
• regular visitor of the pharmacy and the physicians.

Exclusion criteria

• participation in other intervention study during this study,
• living in other cities,
• could not participate in all visits of the study

Trial design

Primary purpose: Health Services Research

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

40 participants in 2 patient groups

Dispensing only

No Intervention group

Description:

Non clinical pharmacists will dispense drugs to patients and usual care will be offered.

Pharmaceutical care

Experimental group

Description:

Patients on experimental group will receive counseling and education on the asthma condition, medication and lifestyle issues. In all visits, the inhaler technique will be reviewed, adherence to treatment and drug related problems were checked. If necessary the patient will be referred to the respiratory specialist to change the medication or to prescribe dose adjustment. Pharmacists document their initial and monthly follow up encounters using a specified form.

Treatment:

Other: Pharmaceutical care